The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients
To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to...
Gespeichert in:
| Veröffentlicht in: | Cell biochemistry and biophysics 2015-03, Vol.71 (2), p.957-961 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 961 |
|---|---|
| container_issue | 2 |
| container_start_page | 957 |
| container_title | Cell biochemistry and biophysics |
| container_volume | 71 |
| creator | Jia, Fengyu Rong, Peng Li, Dandan Wang, Suxia Jing, Ying Ge, Yanming Meng, Jianzhong |
| description | To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (
P
|
| doi_str_mv | 10.1007/s12013-014-0293-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1652445473</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3579702151</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-e0a3b5de7ec384646399ff14e2beff85e2f2f343e8a958efe7c6cb1a5fd41ba93</originalsourceid><addsrcrecordid>eNp1kFtLwzAYhoMobk5_gDdS8Mabao49XOqYBxAcOC8lpO2X2dElM2lh-_dm6xQRhEAS8rxvkgehc4KvCcbpjScUExZjwmNMcxavD9CQCJGHXcYOwxpnIs5JLgboxPsFxpRizo_RgAqGecrpEL3PPiCaaA1lG1kdja1pa9PZzkd3jbVVNO1cretStbU1URhtwKfOzo31td8llKtq68CoJnrdmMrZZSACD6b1p-hIq8bD2X4eobf7yWz8GD-_PDyNb5_jkqW0jQErVogKUihZxhOesDzXmnCgBWidCaCaasYZZCoXGWhIy6QsiBK64qRQORuhq7535exnB76Vy9qX0DTKQPiLJImgnAuesoBe_kEXtnPh9TuKMMKzhAaK9FTprPcOtFy5eqncRhIst-5l714G93LrXq5D5mLf3BVLqH4S37IDQHvAhyMzB_fr6n9bvwAzK4_5</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1651314862</pqid></control><display><type>article</type><title>The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Jia, Fengyu ; Rong, Peng ; Li, Dandan ; Wang, Suxia ; Jing, Ying ; Ge, Yanming ; Meng, Jianzhong</creator><creatorcontrib>Jia, Fengyu ; Rong, Peng ; Li, Dandan ; Wang, Suxia ; Jing, Ying ; Ge, Yanming ; Meng, Jianzhong</creatorcontrib><description>To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (
P
< 0.01). From 72 to 120 h of CBP treatment, oliguria was resolved in 24 patients, with improved sensitivity to diuretics. The fatality rate at 28 days was 11.12 %. CBP treatment could improve myocardial function, shorten the oliguria period, decrease the fatality rate, and improve the prognosis of CRS patients.</description><identifier>ISSN: 1085-9195</identifier><identifier>EISSN: 1559-0283</identifier><identifier>DOI: 10.1007/s12013-014-0293-x</identifier><identifier>PMID: 25304742</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Aged ; Biochemistry ; Biological and Medical Physics ; Biomedical and Life Sciences ; Biophysics ; Biotechnology ; Blood ; Blood Proteins - metabolism ; Cardio-Renal Syndrome - therapy ; Cell Biology ; Female ; Hemodynamics ; Humans ; Life Sciences ; Male ; Middle Aged ; Mortality ; Original Paper ; Pharmacology/Toxicology ; Prognosis ; Proteinase inhibitors ; Renal Dialysis - adverse effects</subject><ispartof>Cell biochemistry and biophysics, 2015-03, Vol.71 (2), p.957-961</ispartof><rights>Springer Science+Business Media New York 2014</rights><rights>Springer Science+Business Media New York 2015</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c372t-e0a3b5de7ec384646399ff14e2beff85e2f2f343e8a958efe7c6cb1a5fd41ba93</citedby><cites>FETCH-LOGICAL-c372t-e0a3b5de7ec384646399ff14e2beff85e2f2f343e8a958efe7c6cb1a5fd41ba93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s12013-014-0293-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s12013-014-0293-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27931,27932,41495,42564,51326</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25304742$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jia, Fengyu</creatorcontrib><creatorcontrib>Rong, Peng</creatorcontrib><creatorcontrib>Li, Dandan</creatorcontrib><creatorcontrib>Wang, Suxia</creatorcontrib><creatorcontrib>Jing, Ying</creatorcontrib><creatorcontrib>Ge, Yanming</creatorcontrib><creatorcontrib>Meng, Jianzhong</creatorcontrib><title>The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients</title><title>Cell biochemistry and biophysics</title><addtitle>Cell Biochem Biophys</addtitle><addtitle>Cell Biochem Biophys</addtitle><description>To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (
P
< 0.01). From 72 to 120 h of CBP treatment, oliguria was resolved in 24 patients, with improved sensitivity to diuretics. The fatality rate at 28 days was 11.12 %. CBP treatment could improve myocardial function, shorten the oliguria period, decrease the fatality rate, and improve the prognosis of CRS patients.</description><subject>Aged</subject><subject>Biochemistry</subject><subject>Biological and Medical Physics</subject><subject>Biomedical and Life Sciences</subject><subject>Biophysics</subject><subject>Biotechnology</subject><subject>Blood</subject><subject>Blood Proteins - metabolism</subject><subject>Cardio-Renal Syndrome - therapy</subject><subject>Cell Biology</subject><subject>Female</subject><subject>Hemodynamics</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Original Paper</subject><subject>Pharmacology/Toxicology</subject><subject>Prognosis</subject><subject>Proteinase inhibitors</subject><subject>Renal Dialysis - adverse effects</subject><issn>1085-9195</issn><issn>1559-0283</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kFtLwzAYhoMobk5_gDdS8Mabao49XOqYBxAcOC8lpO2X2dElM2lh-_dm6xQRhEAS8rxvkgehc4KvCcbpjScUExZjwmNMcxavD9CQCJGHXcYOwxpnIs5JLgboxPsFxpRizo_RgAqGecrpEL3PPiCaaA1lG1kdja1pa9PZzkd3jbVVNO1cretStbU1URhtwKfOzo31td8llKtq68CoJnrdmMrZZSACD6b1p-hIq8bD2X4eobf7yWz8GD-_PDyNb5_jkqW0jQErVogKUihZxhOesDzXmnCgBWidCaCaasYZZCoXGWhIy6QsiBK64qRQORuhq7535exnB76Vy9qX0DTKQPiLJImgnAuesoBe_kEXtnPh9TuKMMKzhAaK9FTprPcOtFy5eqncRhIst-5l714G93LrXq5D5mLf3BVLqH4S37IDQHvAhyMzB_fr6n9bvwAzK4_5</recordid><startdate>20150301</startdate><enddate>20150301</enddate><creator>Jia, Fengyu</creator><creator>Rong, Peng</creator><creator>Li, Dandan</creator><creator>Wang, Suxia</creator><creator>Jing, Ying</creator><creator>Ge, Yanming</creator><creator>Meng, Jianzhong</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88A</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>RC3</scope><scope>7X8</scope></search><sort><creationdate>20150301</creationdate><title>The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients</title><author>Jia, Fengyu ; Rong, Peng ; Li, Dandan ; Wang, Suxia ; Jing, Ying ; Ge, Yanming ; Meng, Jianzhong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-e0a3b5de7ec384646399ff14e2beff85e2f2f343e8a958efe7c6cb1a5fd41ba93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Biochemistry</topic><topic>Biological and Medical Physics</topic><topic>Biomedical and Life Sciences</topic><topic>Biophysics</topic><topic>Biotechnology</topic><topic>Blood</topic><topic>Blood Proteins - metabolism</topic><topic>Cardio-Renal Syndrome - therapy</topic><topic>Cell Biology</topic><topic>Female</topic><topic>Hemodynamics</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Original Paper</topic><topic>Pharmacology/Toxicology</topic><topic>Prognosis</topic><topic>Proteinase inhibitors</topic><topic>Renal Dialysis - adverse effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jia, Fengyu</creatorcontrib><creatorcontrib>Rong, Peng</creatorcontrib><creatorcontrib>Li, Dandan</creatorcontrib><creatorcontrib>Wang, Suxia</creatorcontrib><creatorcontrib>Jing, Ying</creatorcontrib><creatorcontrib>Ge, Yanming</creatorcontrib><creatorcontrib>Meng, Jianzhong</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cell biochemistry and biophysics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jia, Fengyu</au><au>Rong, Peng</au><au>Li, Dandan</au><au>Wang, Suxia</au><au>Jing, Ying</au><au>Ge, Yanming</au><au>Meng, Jianzhong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients</atitle><jtitle>Cell biochemistry and biophysics</jtitle><stitle>Cell Biochem Biophys</stitle><addtitle>Cell Biochem Biophys</addtitle><date>2015-03-01</date><risdate>2015</risdate><volume>71</volume><issue>2</issue><spage>957</spage><epage>961</epage><pages>957-961</pages><issn>1085-9195</issn><eissn>1559-0283</eissn><abstract>To discuss the effect of continuous blood purification (CBP) on the prognosis of cardiorenal syndrome (CRS) patients. Twenty-seven patients were selected for this study, who had previously been treated at the Blood Purification Center of the General Hospital of Jinan Military Region from May 2007 to October 2010. All patients suffered from chronic heart failure and acute kidney injury. Using a non-invasive hemodynamics monitoring system, we observed the dynamic changes in their cardiac output (CO), systemic vascular resistance (SVR), thoracic fluid capacity (TFC), central venous pressure (CVP), urinary volume, and Acute Physiology and Chronic Health Evaluation II system (APACHEII) score. Individual measurements were obtained at 24 h, 48 h, 72 h, 96 h, and 120 h after CBP treatment. At the same time, levels of serum creatinine (Scr), cysteine proteinase inhibitor Cystatin C (CysC), high sensitivity C-reactive protein (hs-CRP), and serum sodium were observed. The fatality rate at 28 days was also recorded. After 24 h of CBP treatment, acidosis, CO, and disturbances in water and electrolyte levels were all improved. As well, concentrations of Scr and CysC were significantly decreased, and the levels of SVR, TFC, and CVP were also decreased. After 72 h of CBP treatment, hs-CRP levels and APACHE II scores were significantly lower (
P
< 0.01). From 72 to 120 h of CBP treatment, oliguria was resolved in 24 patients, with improved sensitivity to diuretics. The fatality rate at 28 days was 11.12 %. CBP treatment could improve myocardial function, shorten the oliguria period, decrease the fatality rate, and improve the prognosis of CRS patients.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>25304742</pmid><doi>10.1007/s12013-014-0293-x</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1085-9195 |
| ispartof | Cell biochemistry and biophysics, 2015-03, Vol.71 (2), p.957-961 |
| issn | 1085-9195 1559-0283 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1652445473 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Aged Biochemistry Biological and Medical Physics Biomedical and Life Sciences Biophysics Biotechnology Blood Blood Proteins - metabolism Cardio-Renal Syndrome - therapy Cell Biology Female Hemodynamics Humans Life Sciences Male Middle Aged Mortality Original Paper Pharmacology/Toxicology Prognosis Proteinase inhibitors Renal Dialysis - adverse effects |
| title | The Effect of Continuous Blood Purification on the Prognosis of Cardiorenal Syndrome Patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T00%3A00%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Effect%20of%20Continuous%20Blood%20Purification%20on%20the%20Prognosis%20of%20Cardiorenal%20Syndrome%20Patients&rft.jtitle=Cell%20biochemistry%20and%20biophysics&rft.au=Jia,%20Fengyu&rft.date=2015-03-01&rft.volume=71&rft.issue=2&rft.spage=957&rft.epage=961&rft.pages=957-961&rft.issn=1085-9195&rft.eissn=1559-0283&rft_id=info:doi/10.1007/s12013-014-0293-x&rft_dat=%3Cproquest_cross%3E3579702151%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1651314862&rft_id=info:pmid/25304742&rfr_iscdi=true |